This article is a stub. Please feel free to expand it and make it more encyclopaedic.
From the HPA web site:
"Lymphogranuloma venereum (LGV) is a sexually transmitted disease caused by a specific type of Chlamydia trachomatis (serovars L1, L2, and L3). LGV is highly prevalent in parts of Africa, Asia, and South America but has been rare in Western Europe for many decades.
"Since 2003 a series of outbreaks of LGV have been reported in European cities among men who have sex with men (MSM). All current European outbreaks are of the L2 genotype. Most cases present with proctitis, are of white ethnicity, and are HIV-positive."
An enhanced surveillance system has been established to monitor LGV disease. The Health Protection Agency provides a free diagnostic service for patients/samples meeting certain criteria - see this page on the HPA web site for more details.
Post exposure prophylaxis
- HPA web page on LGV
- Guidelines on the management of LGV from BASSH
- Lorek JD, Acker SM, Langenstroer P, Datta MW. Lymphogranuloma Venereum. 2005, eMedicine
- Andrew C Bushnell AC. Lymphogranuloma Venereum. 2005, eMedicine
- Chlamydial genital tract infections. Lymphogranuloma venereum: Introduction. from chlamydiae.com professional
- Mabey D, Peeling RW. Lymphogranuloma venereum (Review). Sex Transm Infect. 2002 Apr;78(2):90-2.
- Basic Summary for Lymphogranuloma venereum from "Wrongdiagnosis.com"
- Factsheet for patients on Lymphogranuloma Venereum from New York State Department of Health
- Handbook of Dermatology & Venereology chapter on Lymphogranuloma Venereum
- Medline Plus Medical Encyclopedia article on Lymphogranuloma Venereum